|
US4000259A
(en)
|
1975-06-16 |
1976-12-28 |
American Home Products Corporation |
Cyclic dodecapeptide analogs of somatostatin and intermediates
|
|
US4438270A
(en)
|
1977-07-11 |
1984-03-20 |
Merrell Toraude Et Compagnie |
α-Halomethyl derivatives of α-amino acids
|
|
US4191754A
(en)
|
1979-02-28 |
1980-03-04 |
Merck & Co., Inc. |
Bicyclic somatostatin analogs
|
|
US4270537A
(en)
|
1979-11-19 |
1981-06-02 |
Romaine Richard A |
Automatic hypodermic syringe
|
|
AU550730B2
(en)
|
1982-03-09 |
1986-04-10 |
Commonwealth Of Australia, The |
Automated metal detection
|
|
US4728726A
(en)
|
1982-10-04 |
1988-03-01 |
The Salk Institute For Biological Studies |
GRF analogs IIIb
|
|
US4518586A
(en)
|
1983-01-13 |
1985-05-21 |
The Salk Institute For Biological Studies |
GRF Analogs III
|
|
US5416073A
(en)
|
1983-08-10 |
1995-05-16 |
The Adminstrators Of The Tulane Educational Fund |
Growth hormone-releasing peptides and method of treating animals, therewith
|
|
US4596556A
(en)
|
1985-03-25 |
1986-06-24 |
Bioject, Inc. |
Hypodermic injection apparatus
|
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
US5036045A
(en)
|
1985-09-12 |
1991-07-30 |
The University Of Virginia Alumni Patents Foundation |
Method for increasing growth hormone secretion
|
|
US4730006A
(en)
|
1986-01-27 |
1988-03-08 |
Merrell Dow Pharmaceuticals Inc. |
Derivatives of 2,6-diamino-3-haloheptanedioic acid
|
|
US4880778A
(en)
|
1986-05-12 |
1989-11-14 |
Eastman Kodak Company |
Combinations having synergistic growth hormone releasing activity and methods for use thereof
|
|
HU906341D0
(en)
|
1986-10-13 |
1991-04-29 |
Sandoz Ag |
Process for producing peptonic derivatives modified with sugar and pharmaceutical preparatives containing these compounds as active substance
|
|
CA1283827C
(en)
|
1986-12-18 |
1991-05-07 |
Giorgio Cirelli |
Appliance for injection of liquid formulations
|
|
GB8704027D0
(en)
|
1987-02-20 |
1987-03-25 |
Owen Mumford Ltd |
Syringe needle combination
|
|
US5112808A
(en)
|
1987-05-11 |
1992-05-12 |
American Cyanamid Company |
Alkylated hormone-releasing peptides and method of treatig mammals therewith
|
|
US4941880A
(en)
|
1987-06-19 |
1990-07-17 |
Bioject, Inc. |
Pre-filled ampule and non-invasive hypodermic injection device assembly
|
|
US4790824A
(en)
|
1987-06-19 |
1988-12-13 |
Bioject, Inc. |
Non-invasive hypodermic injection device
|
|
US4940460A
(en)
|
1987-06-19 |
1990-07-10 |
Bioject, Inc. |
Patient-fillable and non-invasive hypodermic injection device assembly
|
|
US5877277A
(en)
|
1987-09-24 |
1999-03-02 |
Biomeasure, Inc. |
Octapeptide bombesin analogs
|
|
US5453418A
(en)
|
1988-03-07 |
1995-09-26 |
Eli Lilly And Company |
Ractopamine and growth hormone combinations
|
|
US5339163A
(en)
|
1988-03-16 |
1994-08-16 |
Canon Kabushiki Kaisha |
Automatic exposure control device using plural image plane detection areas
|
|
AU3439589A
(en)
|
1988-03-24 |
1989-10-16 |
Terrapin Diagnostics, Inc. |
Molecular sticks for controlling protein conformation
|
|
US5094951A
(en)
|
1988-06-21 |
1992-03-10 |
Chiron Corporation |
Production of glucose oxidase in recombinant systems
|
|
US5043322A
(en)
*
|
1988-07-22 |
1991-08-27 |
The Salk Institute For Biological Studies |
Cyclic GRF analogs
|
|
FR2638359A1
(fr)
|
1988-11-03 |
1990-05-04 |
Tino Dalto |
Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
|
|
US5384309A
(en)
|
1989-07-17 |
1995-01-24 |
Genentech, Inc. |
Cyclized peptides and their use as platelet aggregation inhibitors
|
|
US5120859A
(en)
|
1989-09-22 |
1992-06-09 |
Genentech, Inc. |
Chimeric amino acid analogues
|
|
US5650133A
(en)
|
1990-01-19 |
1997-07-22 |
Nycomed Salutar |
Macrocyclic polyaza dichelates linked through ring nitrogens via an amide or ester functionality
|
|
US5712418A
(en)
|
1989-10-23 |
1998-01-27 |
Research Corporation Technologies, Inc. |
Synthesis and use of amino acid fluorides as peptide coupling reagents
|
|
US5296468A
(en)
|
1989-10-30 |
1994-03-22 |
The Salk Institute For Biological Studies |
GnRH analogs
|
|
US5352796A
(en)
|
1989-10-30 |
1994-10-04 |
The Salk Institute For Biological Studies |
Amino acids useful in making GnRH analogs
|
|
US5169932A
(en)
|
1989-10-30 |
1992-12-08 |
The Salk Institute For Biological Studies |
Gnrh analogs
|
|
US5580957A
(en)
|
1989-10-30 |
1996-12-03 |
The Salk Institute For Biological Studies |
GnRH analogs
|
|
US5064413A
(en)
|
1989-11-09 |
1991-11-12 |
Bioject, Inc. |
Needleless hypodermic injection device
|
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
US5245009A
(en)
|
1990-03-23 |
1993-09-14 |
The Salk Institute For Biological Studies |
CRF antagonists
|
|
CA2047042A1
(en)
|
1990-07-19 |
1992-01-20 |
John Hannah |
Cyclic hiv principal neutralizing determinant peptides
|
|
US5714167A
(en)
|
1992-06-15 |
1998-02-03 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
|
US6331318B1
(en)
|
1994-09-30 |
2001-12-18 |
Emisphere Technologies Inc. |
Carbon-substituted diketopiperazine delivery systems
|
|
US5629020A
(en)
|
1994-04-22 |
1997-05-13 |
Emisphere Technologies, Inc. |
Modified amino acids for drug delivery
|
|
US5190521A
(en)
|
1990-08-22 |
1993-03-02 |
Tecnol Medical Products, Inc. |
Apparatus and method for raising a skin wheal and anesthetizing skin
|
|
EP0552238A1
(de)
|
1990-10-11 |
1993-07-28 |
BOEHRINGER INGELHEIM INTERNATIONAL GmbH |
Cyclopeptide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
|
DE69118826T2
(de)
|
1990-11-27 |
1996-11-14 |
Fuji Photo Film Co Ltd |
Propenamidderivate, deren Polymere, Copolymere und deren Verwendung
|
|
US5124454A
(en)
|
1990-11-30 |
1992-06-23 |
Minnesota Mining And Manufacturing Company |
Polycyclic diamines and method of preparation
|
|
US5527288A
(en)
|
1990-12-13 |
1996-06-18 |
Elan Medical Technologies Limited |
Intradermal drug delivery device and method for intradermal delivery of drugs
|
|
EP0573608A1
(en)
|
1991-02-07 |
1993-12-15 |
Molecumetics, Ltd. |
Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same
|
|
US5747469A
(en)
|
1991-03-06 |
1998-05-05 |
Board Of Regents, The University Of Texas System |
Methods and compositions comprising DNA damaging agents and p53
|
|
US5744450A
(en)
|
1991-03-14 |
1998-04-28 |
The Salk Institute For Biological Studies |
GnRH analogs
|
|
AU662731B2
(en)
|
1991-04-09 |
1995-09-14 |
F. Hoffmann-La Roche Ag |
Growth hormone releasing factor analogs
|
|
US5262519A
(en)
|
1991-05-15 |
1993-11-16 |
The Salk Institute For Biological Studies |
GRF analogs XI
|
|
US5364851A
(en)
|
1991-06-14 |
1994-11-15 |
International Synthecon, Llc |
Conformationally restricted biologically active peptides, methods for their production and uses thereof
|
|
CA2072249C
(en)
|
1991-06-28 |
2003-06-17 |
Saiko Hosokawa |
Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane
|
|
GB9114949D0
(en)
|
1991-07-11 |
1991-08-28 |
Smithkline Beecham Plc |
Novel compounds
|
|
DE69220861T2
(de)
|
1991-08-13 |
1997-11-20 |
Takeda Chemical Industries Ltd |
Zyklische Peptide und ihre Verwendung
|
|
US7517644B1
(en)
|
1991-08-23 |
2009-04-14 |
Larry J. Smith |
Method and compositions for cellular reprogramming
|
|
GB9118204D0
(en)
|
1991-08-23 |
1991-10-09 |
Weston Terence E |
Needle-less injector
|
|
SE9102652D0
(sv)
|
1991-09-13 |
1991-09-13 |
Kabi Pharmacia Ab |
Injection needle arrangement
|
|
IL103252A
(en)
|
1991-09-30 |
1997-03-18 |
Du Pont Merck Pharma |
CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
|
|
EP0552417B1
(en)
|
1991-11-19 |
1999-07-07 |
Takeda Chemical Industries, Ltd. |
Cyclic peptides and use thereof
|
|
US5328483A
(en)
|
1992-02-27 |
1994-07-12 |
Jacoby Richard M |
Intradermal injection device with medication and needle guard
|
|
AU691645B2
(en)
|
1992-04-03 |
1998-05-21 |
California Institute Of Technology |
High activity ruthenium or osmium metal carbene complexes for olefin metathesis reactions and synthesis thereof
|
|
US5411860A
(en)
|
1992-04-07 |
1995-05-02 |
The Johns Hopkins University |
Amplification of human MDM2 gene in human tumors
|
|
ATE183514T1
(de)
|
1992-05-26 |
1999-09-15 |
Univ Leiden |
Peptide des menschlichen proteins p53 zum gebrauch in menschlichen-zytotoxischen-t-zell- antwort-induzierenden kompositionen sowie menschliche p53-protein-spezifische t-lymphocyten
|
|
US5323907A
(en)
|
1992-06-23 |
1994-06-28 |
Multi-Comp, Inc. |
Child resistant package assembly for dispensing pharmaceutical medications
|
|
EP0651761B1
(en)
|
1992-07-13 |
2002-10-09 |
Bionebraska, Inc. |
Method for modification of recombinant polypeptides
|
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
US5569189A
(en)
|
1992-09-28 |
1996-10-29 |
Equidyne Systems, Inc. |
hypodermic jet injector
|
|
US5334144A
(en)
|
1992-10-30 |
1994-08-02 |
Becton, Dickinson And Company |
Single use disposable needleless injector
|
|
US5371070A
(en)
|
1992-11-09 |
1994-12-06 |
The Salk Institute For Biological Studies |
Bicyclic GnRH antagonists and a method for regulating the secretion of gonadotropins
|
|
CA2151742C
(en)
|
1993-02-22 |
1999-05-25 |
Alfred A. Amkraut |
Compositions for oral delivery of active agents
|
|
HUT72896A
(en)
|
1993-03-29 |
1996-06-28 |
Du Pont Merck Pharma |
Cyclic compounds useful as inhibitors of platelet glycoprotein iib/iiia
|
|
US5643957A
(en)
|
1993-04-22 |
1997-07-01 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
|
CA2161108A1
(en)
|
1993-04-23 |
1994-11-10 |
Herbert J. Evans |
Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
|
|
US5446128A
(en)
|
1993-06-18 |
1995-08-29 |
The Board Of Trustees Of The University Of Illinois |
Alpha-helix mimetics and methods relating thereto
|
|
PT1288223E
(pt)
|
1993-08-09 |
2005-03-31 |
Sod Conseils Rech Applic |
Derivados de peptidos terapeuticos
|
|
US5622852A
(en)
|
1994-10-31 |
1997-04-22 |
Washington University |
Bcl-x/Bcl-2 associated cell death regulator
|
|
US5536814A
(en)
|
1993-09-27 |
1996-07-16 |
La Jolla Cancer Research Foundation |
Integrin-binding peptides
|
|
WO1995014777A1
(en)
|
1993-11-22 |
1995-06-01 |
Onyx Pharmaceuticals |
p53-BINDING POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME
|
|
US6287787B1
(en)
|
1993-11-24 |
2001-09-11 |
Torrey Pines Institute For Molecular Studies |
Dimeric oligopeptide mixture sets
|
|
CA2183562A1
(en)
|
1994-02-18 |
1995-08-24 |
J. Peter Klein |
Intracellular signalling mediators
|
|
WO1995024176A1
(en)
|
1994-03-07 |
1995-09-14 |
Bioject, Inc. |
Ampule filling device
|
|
US5466220A
(en)
|
1994-03-08 |
1995-11-14 |
Bioject, Inc. |
Drug vial mixing and transfer device
|
|
US5506207A
(en)
|
1994-03-18 |
1996-04-09 |
The Salk Institute For Biological Studies |
GNRH antagonists XIII
|
|
US5824483A
(en)
|
1994-05-18 |
1998-10-20 |
Pence Inc. |
Conformationally-restricted combinatiorial library composition and method
|
|
JP3166482B2
(ja)
|
1994-06-07 |
2001-05-14 |
日産自動車株式会社 |
反射干渉作用を有する発色構造体
|
|
IL109943A
(en)
|
1994-06-08 |
2006-08-01 |
Develogen Israel Ltd |
Conformationally constrained backbone cyclized peptide analogs
|
|
US6407059B1
(en)
|
1994-06-08 |
2002-06-18 |
Peptor Limited |
Conformationally constrained backbone cyclized peptide analogs
|
|
US7553929B2
(en)
|
1994-06-13 |
2009-06-30 |
Vanderbilt University |
Cell permeable peptides for inhibition of inflammatory reactions and methods of use
|
|
US5807746A
(en)
|
1994-06-13 |
1998-09-15 |
Vanderbilt University |
Method for importing biologically active molecules into cells
|
|
US5702908A
(en)
|
1994-07-20 |
1997-12-30 |
University Of Dundee |
Interruption of binding of MDM2 and p53 protein and therapeutic application thereof
|
|
US5770377A
(en)
|
1994-07-20 |
1998-06-23 |
University Of Dundee |
Interruption of binding of MDM2 and P53 protein and therapeutic application thereof
|
|
AU714966B2
(en)
|
1994-09-19 |
2000-01-13 |
Ricardo J Moro |
Detection and treatment of cancer
|
|
CA2158782C
(en)
|
1994-09-23 |
2010-01-12 |
Pierrette Gaudreau |
Marker for growth hormone-releasing factor receptors
|
|
US5681928A
(en)
|
1994-12-16 |
1997-10-28 |
The Salk Institute For Biological Studies |
Betides and methods for screening peptides using same
|
|
ATE544776T1
(de)
|
1994-12-29 |
2012-02-15 |
Massachusetts Inst Technology |
Chimäre dna-bindeproteine
|
|
US5599302A
(en)
|
1995-01-09 |
1997-02-04 |
Medi-Ject Corporation |
Medical injection system and method, gas spring thereof and launching device using gas spring
|
|
US5792747A
(en)
|
1995-01-24 |
1998-08-11 |
The Administrators Of The Tulane Educational Fund |
Highly potent agonists of growth hormone releasing hormone
|
|
US6169073B1
(en)
|
1995-02-16 |
2001-01-02 |
Bayer Corporation |
Peptides and peptidomimetics with structural similarity to human p53 that activate p53 function
|
|
EP0729972A1
(de)
|
1995-02-28 |
1996-09-04 |
F. Hoffmann-La Roche Ag |
Tetrahydronaphthalin-Peptidderivate
|
|
US6514942B1
(en)
|
1995-03-14 |
2003-02-04 |
The Board Of Regents, The University Of Texas System |
Methods and compositions for stimulating T-lymphocytes
|
|
US5675001A
(en)
|
1995-03-14 |
1997-10-07 |
Hoffman/Barrett, L.L.C. |
Heteroatom-functionalized porphyrazines and multimetallic complexes and polymers derived therefrom
|
|
US5700775A
(en)
|
1995-03-24 |
1997-12-23 |
Gutniak; Mark K. |
Method and treatment composition for decreasing patient time in catabolic state after traumatic injury
|
|
US6090958A
(en)
|
1995-03-31 |
2000-07-18 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
|
BR9604880A
(pt)
|
1995-03-31 |
1998-05-19 |
Emisphere Tech Inc |
Composto composição forma de unidade de dosagem métodos para administração de um agente biologicamente ativo para preparar uma composição para administração de um agente ativo e para preparar um composto e composição farmacológica
|
|
US5650386A
(en)
|
1995-03-31 |
1997-07-22 |
Emisphere Technologies, Inc. |
Compositions for oral delivery of active agents
|
|
US6054556A
(en)
|
1995-04-10 |
2000-04-25 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Melanocortin receptor antagonists and agonists
|
|
US5731408A
(en)
|
1995-04-10 |
1998-03-24 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Peptides having potent antagonist and agonist bioactivities at melanocortin receptors
|
|
JPH11503454A
(ja)
|
1995-04-14 |
1999-03-26 |
ジ アドミニストレイターズ オブ ザ チューレン エデュケイショナル ファンド |
成長ホルモン放出因子の類似体
|
|
US5672584A
(en)
|
1995-04-25 |
1997-09-30 |
The University Of Kansas |
Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability
|
|
US6184344B1
(en)
|
1995-05-04 |
2001-02-06 |
The Scripps Research Institute |
Synthesis of proteins by native chemical ligation
|
|
DK0832096T3
(da)
|
1995-05-04 |
2001-10-01 |
Scripps Research Inst |
Syntese af proteiner ved nativ kemisk ligering
|
|
US5730723A
(en)
|
1995-10-10 |
1998-03-24 |
Visionary Medical Products Corporation, Inc. |
Gas pressured needle-less injection device and method
|
|
US6458764B1
(en)
|
1995-05-26 |
2002-10-01 |
Theratechnologies Inc. |
GRF analogs with increased biological potency
|
|
US6020311A
(en)
|
1995-05-26 |
2000-02-01 |
Theratechnologies, Inc. |
GRF analogs with increased biological potency
|
|
DE69614849T2
(de)
|
1995-05-26 |
2002-05-16 |
Theratechnologies Inc., Montreal |
Chimäre lipidkörper-pro-grf analoge mit erhöheter biologischer potenz
|
|
US5817789A
(en)
|
1995-06-06 |
1998-10-06 |
Transkaryotic Therapies, Inc. |
Chimeric proteins for use in transport of a selected substance into cells
|
|
US6051554A
(en)
|
1995-06-07 |
2000-04-18 |
Peptor Limited |
Conformationally constrained backbone cyclized somatostatin analogs
|
|
US6413994B1
(en)
|
1999-02-22 |
2002-07-02 |
The Salk Institute For Biological Studies |
Modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof
|
|
US5811515A
(en)
|
1995-06-12 |
1998-09-22 |
California Institute Of Technology |
Synthesis of conformationally restricted amino acids, peptides, and peptidomimetics by catalytic ring closing metathesis
|
|
FR2738151B1
(fr)
|
1995-09-04 |
1997-09-26 |
Rhone Poulenc Rorer Sa |
Antagonistes de l'activite oncogenique de la proteine mdm2, et leur utilisation dans le traitement des cancers
|
|
EP0766966A3
(en)
|
1995-09-08 |
2001-02-28 |
Eli Lilly And Company |
Method of treating insulin resistance
|
|
US5750499A
(en)
|
1995-10-18 |
1998-05-12 |
The Salk Institute For Biological Studies |
Receptor-selective somatostatin analogs
|
|
GB9521544D0
(en)
|
1995-10-20 |
1995-12-20 |
Univ Dundee |
Activation of P53 protein and therapeutic applications thereof
|
|
US6123964A
(en)
|
1995-10-27 |
2000-09-26 |
Merck & Co., Inc. |
Wet granulation formulation of a growth hormone secretagogue
|
|
US5840833A
(en)
|
1995-10-27 |
1998-11-24 |
Molecumetics, Ltd |
Alpha-helix mimetics and methods relating thereto
|
|
EP0869974B1
(en)
|
1995-12-22 |
2009-03-04 |
Novo Nordisk A/S |
Compounds with growth hormone releasing properties
|
|
US5807983A
(en)
|
1995-12-28 |
1998-09-15 |
The Salk Institute For Biological Studies |
GNRH antagonist betides
|
|
US5893397A
(en)
|
1996-01-12 |
1999-04-13 |
Bioject Inc. |
Medication vial/syringe liquid-transfer apparatus
|
|
AU6162996A
(en)
|
1996-01-17 |
1997-08-11 |
California Institute Of Technology |
Synthesis of conformationally restricted amino acids, peptides and peptidomimetics by catalytic ring closing metathesis
|
|
US5849954A
(en)
|
1996-01-18 |
1998-12-15 |
Research Corporation Technologies, Inc. |
Method of peptide synthesis
|
|
WO1997026278A1
(en)
|
1996-01-18 |
1997-07-24 |
Steeno Research Group A/S |
Synthetic il-10 analogues
|
|
US5849691A
(en)
|
1996-02-20 |
1998-12-15 |
The United States Of America As Represented By The Department Of Health And Human Services |
Peptidomimetic inhibitors of cathepsin D and plasmepsins I and II
|
|
SI9720025A
(sl)
|
1996-03-29 |
1999-08-31 |
Emishphere Technologies, Inc. |
Spojine in sestavki za prenos aktivne snovi
|
|
GB9607549D0
(en)
|
1996-04-11 |
1996-06-12 |
Weston Medical Ltd |
Spring-powered dispensing device
|
|
JP3792777B2
(ja)
|
1996-05-10 |
2006-07-05 |
株式会社カネカ |
１−アルコキシカルボニル−３−フェニルプロピル誘導体の製造方法
|
|
AU3220097A
(en)
|
1996-05-22 |
1997-12-09 |
Arch Development Corporation |
Sleep quality improvement using a growth hormone secretagogue
|
|
US5817752A
(en)
|
1996-06-06 |
1998-10-06 |
La Jolla Pharmaceutical Company |
Cyclic polypeptides comprising a thioether linkage and methods for their preparation
|
|
US5817627A
(en)
|
1996-06-14 |
1998-10-06 |
Theratechnologies Inc. |
Long-acting galenical formulation for GRF peptides
|
|
ATE185146T1
(de)
|
1996-06-14 |
1999-10-15 |
Takeda Chemical Industries Ltd |
Verfahren zur entfernung von n-terminalem methionin
|
|
US5663316A
(en)
|
1996-06-18 |
1997-09-02 |
Clontech Laboratories, Inc. |
BBC6 gene for regulation of cell death
|
|
US7083983B2
(en)
|
1996-07-05 |
2006-08-01 |
Cancer Research Campaign Technology Limited |
Inhibitors of the interaction between P53 and MDM2
|
|
ATE397621T1
(de)
|
1996-07-05 |
2008-06-15 |
Cancer Rec Tech Ltd |
Hemmer der interaktion zwischen p53 und mdm2
|
|
JP4425992B2
(ja)
|
1996-07-22 |
2010-03-03 |
サファイア セラピューティクス，インコーポレイティド |
成長ホルモン放出特性を有する化合物
|
|
US5955593A
(en)
|
1996-09-09 |
1999-09-21 |
Washington University |
BH3 interacting domain death agonist
|
|
US20020064546A1
(en)
|
1996-09-13 |
2002-05-30 |
J. Milton Harris |
Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor
|
|
US5965703A
(en)
|
1996-09-20 |
1999-10-12 |
Idun Pharmaceuticals |
Human bad polypeptides, encoding nucleic acids and methods of use
|
|
GB9619757D0
(en)
|
1996-09-21 |
1996-11-06 |
Knoll Ag |
Chemical process
|
|
US5856445A
(en)
|
1996-10-18 |
1999-01-05 |
Washington University |
Serine substituted mutants of BCL-XL /BCL-2 associated cell death regulator
|
|
JP4024309B2
(ja)
|
1996-10-22 |
2007-12-19 |
第一三共株式会社 |
新規な感染症治療薬
|
|
US6271198B1
(en)
|
1996-11-06 |
2001-08-07 |
Genentech, Inc. |
Constrained helical peptides and methods of making same
|
|
AU734337B2
(en)
|
1996-11-21 |
2001-06-14 |
Promega Corporation |
Alkyl peptide amides and applications
|
|
US6313088B1
(en)
|
1997-02-07 |
2001-11-06 |
Emisphere Technologies, Inc. |
8-[(2-hydroxy-4-methoxy benzoyl) amino]-octanoic acid compositions for delivering active agents
|
|
US6060513A
(en)
|
1997-02-07 |
2000-05-09 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
|
BR9807456A
(pt)
|
1997-02-20 |
2000-04-25 |
Yeda Res & Dev |
Peptìdios antipatogênicos sintéticos e composições que compreendem os mesmos
|
|
US6849428B1
(en)
|
1997-03-05 |
2005-02-01 |
New England Biolabs, Inc. |
Intein-mediated protein ligation of expressed proteins
|
|
US6635740B1
(en)
|
1997-03-27 |
2003-10-21 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Ligand/lytic peptide compositions and methods of use
|
|
JP2002506423A
(ja)
|
1997-04-11 |
2002-02-26 |
イーライ・リリー・アンド・カンパニー |
ペプチド模倣型大員環のコンビナトリアルライブラリーとそのための方法
|
|
GB9708092D0
(en)
|
1997-04-22 |
1997-06-11 |
Univ Dundee |
Materials and methods relating to inhibiting the interaction of p53 and mdm2
|
|
US6329368B1
(en)
|
1997-05-09 |
2001-12-11 |
The Regents Of The University Of California |
Endocrine modulation with positive modulators of AMPA type glutamate receptors
|
|
CA2289960A1
(en)
|
1997-05-15 |
1998-11-19 |
Kyowa Hakko Kogyo Co., Ltd. |
Peptides having a cyclic structure and restoring the activities of p53 protein to mutant p53 protein
|
|
US5993412A
(en)
|
1997-05-19 |
1999-11-30 |
Bioject, Inc. |
Injection apparatus
|
|
US6127341A
(en)
|
1997-06-20 |
2000-10-03 |
Novo Nordisk A/S |
Compounds with growth hormone releasing properties
|
|
US6248358B1
(en)
|
1998-08-25 |
2001-06-19 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets and methods of making and using the same
|
|
JP2001524301A
(ja)
|
1997-09-17 |
2001-12-04 |
ザ・ワルター・アンド・エリザ・ホール・インスティテュート・オヴ・メディカル・リサーチ |
新規治療用分子
|
|
US6420136B1
(en)
|
1997-09-26 |
2002-07-16 |
University Technologies International, Inc. |
Method of modulating p53 activity
|
|
US6165732A
(en)
|
1997-10-14 |
2000-12-26 |
Washington University |
Method for identifying apoptosis modulating compounds
|
|
US6875594B2
(en)
|
1997-11-13 |
2005-04-05 |
The Rockefeller University |
Methods of ligating expressed proteins
|
|
US6177076B1
(en)
|
1997-12-09 |
2001-01-23 |
Thomas Jefferson University |
Method of treating bladder cancer with wild type vaccinia virus
|
|
WO1999034833A1
(en)
|
1998-01-07 |
1999-07-15 |
Shearwater Polymers, Incorporated |
Degradable heterobifunctional poly(ethylene glycol) acrylates and gels and conjugates derived therefrom
|
|
IT1298087B1
(it)
|
1998-01-08 |
1999-12-20 |
Fiderm S R L |
Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
|
|
US6030997A
(en)
|
1998-01-21 |
2000-02-29 |
Eilat; Eran |
Acid labile prodrugs
|
|
IL137388A
(en)
|
1998-01-29 |
2005-05-17 |
Poly Med Inc |
Absorbable microparticles
|
|
EP1051194B9
(en)
|
1998-01-29 |
2003-11-05 |
Kinerton Limited |
Process for making absorbable microparticles
|
|
NZ506839A
(en)
|
1998-03-09 |
2003-05-30 |
Zealand Pharma As |
Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
|
|
AU767185B2
(en)
|
1998-03-23 |
2003-11-06 |
President And Fellows Of Harvard College |
Synthesis of compounds and libraries of compounds
|
|
CZ20003798A3
(cs)
|
1998-04-15 |
2001-08-15 |
Aventis Pharmaceuticals Products, Inc. |
Způsob výroby cyklických peptidů vázaných k polymernímu nosiči
|
|
US6190699B1
(en)
|
1998-05-08 |
2001-02-20 |
Nzl Corporation |
Method of incorporating proteins or peptides into a matrix and administration thereof through mucosa
|
|
AU4543899A
(en)
|
1998-06-08 |
1999-12-30 |
Advanced Medicine, Inc. |
Multibinding inhibitors of microsomal triglyceride transferase protein
|
|
US6326354B1
(en)
|
1998-08-19 |
2001-12-04 |
Washington University |
Modulation of apoptosis with bid
|
|
US7173005B2
(en)
|
1998-09-02 |
2007-02-06 |
Antyra Inc. |
Insulin and IGF-1 receptor agonists and antagonists
|
|
US6194402B1
(en)
|
1998-09-02 |
2001-02-27 |
Merck & Co., Inc. |
Enhancement of return to independent living status with a growth hormone secretagogue
|
|
US6572856B1
(en)
|
1998-09-10 |
2003-06-03 |
The University Of Virginia Patent Foundation |
Methods for the prevention and treatment of cancer using anti-C3b(i) antibodies
|
|
US6696063B1
(en)
|
1998-12-30 |
2004-02-24 |
Applied Research Systems Ars Holding N.V. |
Treatment of HIV-associated dysmorphia/dysmetabolic syndrome (HADDS) with or without lipodystrophy
|
|
US6593353B1
(en)
|
1999-01-29 |
2003-07-15 |
Board Of Trustees Of The University Of Illinois |
p53 inhibitors and therapeutic use of the same
|
|
US6372490B1
(en)
|
1999-02-23 |
2002-04-16 |
Curagen Corporation |
Nucleic acid encoding the MDM interacting protein
|
|
AU777363B2
(en)
|
1999-03-01 |
2004-10-14 |
Nuvelo, Inc. |
Methods for targeting RNA molecules
|
|
AU763510B2
(en)
|
1999-03-29 |
2003-07-24 |
Procter & Gamble Company, The |
Melanocortin receptor ligands
|
|
US6444425B1
(en)
|
1999-04-02 |
2002-09-03 |
Corixa Corporation |
Compounds for therapy and diagnosis of lung cancer and methods for their use
|
|
US6713280B1
(en)
|
1999-04-07 |
2004-03-30 |
Thomas Jefferson University |
Enhancement of peptide cellular uptake
|
|
WO2000064283A1
(en)
|
1999-04-27 |
2000-11-02 |
International Health Products And Services Ltd. |
Supplement for restoring growth hormone levels
|
|
JP4217004B2
(ja)
|
1999-05-17 |
2009-01-28 |
コンジュケム バイオテクノロジーズ インコーポレイテッド |
血液成分への結合体化を介するペプチダーゼ活性からの内因性治療用ペプチドの保護
|
|
US20090175821A1
(en)
|
1999-05-17 |
2009-07-09 |
Bridon Dominique P |
Modified therapeutic peptides with extended half-lives in vivo
|
|
US7192713B1
(en)
|
1999-05-18 |
2007-03-20 |
President And Fellows Of Harvard College |
Stabilized compounds having secondary structure motifs
|
|
WO2000071096A2
(en)
|
1999-05-24 |
2000-11-30 |
Introgen Therapeutics, Inc. |
Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases
|
|
EP1204321B1
(en)
|
1999-07-26 |
2005-11-09 |
Baylor College Of Medicine |
Super-active porcine growth hormone releasing hormone analog
|
|
US6461634B1
(en)
|
1999-08-20 |
2002-10-08 |
Edward Marshall |
Food-based delivery of HGH-stimulating and other nutritional supplements
|
|
US20080032931A1
(en)
|
1999-08-25 |
2008-02-07 |
Steward Lance E |
Activatable clostridial toxins
|
|
US6696418B1
(en)
|
1999-09-01 |
2004-02-24 |
Pfizer Inc. |
Somatostatin antagonists and agonists that act at the SST subtype 2 receptor
|
|
US20020016298A1
(en)
|
1999-09-01 |
2002-02-07 |
Hay Bruce A. |
Somatostatin antagonists and agonists that act at the sst subtype 2 receptor
|
|
US20030181367A1
(en)
|
1999-09-27 |
2003-09-25 |
O'mahony Daniel |
Conjugates of membrane translocating agents and pharmaceutically active agents
|
|
WO2001038355A2
(en)
|
1999-11-22 |
2001-05-31 |
Zymogenetics, Inc. |
Method of forming a peptide-receptor complex with zsig33 and therapeutic use thereof
|
|
US6831155B2
(en)
|
1999-12-08 |
2004-12-14 |
President And Fellows Of Harvard College |
Inhibition of p53 degradation
|
|
US6348558B1
(en)
|
1999-12-10 |
2002-02-19 |
Shearwater Corporation |
Hydrolytically degradable polymers and hydrogels made therefrom
|
|
US6579967B1
(en)
|
1999-12-14 |
2003-06-17 |
The Salk Institute For Biological Studies |
Receptor-selective somatostatin analogs
|
|
WO2001044807A1
(en)
|
1999-12-16 |
2001-06-21 |
Chugai Seiyaku Kabushiki Kaisha |
METHOD OF SCREENING REMEDY FOR CANCER WITH THE USE OF INTERACTION DOMAINS OF p53 AND MORTALIN
|
|
GB0018891D0
(en)
|
2000-08-01 |
2000-09-20 |
Novartis Ag |
Organic compounds
|
|
US20010020012A1
(en)
|
2000-02-01 |
2001-09-06 |
Andersen Maibritt Bansholm |
Use of compounds for the regulation of food intake
|
|
DE10009341A1
(de)
|
2000-02-22 |
2001-09-06 |
Florian Kern |
Verfahren zur antigen-spezifischen Stimulation von T-Lymphozyten
|
|
US6495674B1
(en)
|
2000-02-25 |
2002-12-17 |
The Salk Institute For Biological Studies |
Evectins and their use
|
|
US20020002198A1
(en)
|
2000-04-17 |
2002-01-03 |
Parr Tyler B. |
Chemical synergy to elevate growth hormone release in vertebrates
|
|
US6495589B2
(en)
|
2000-04-28 |
2002-12-17 |
Pfizer Inc. |
Somatostatin antagonists and agonists that act at the SST subtype 2 receptor
|
|
US6897286B2
(en)
|
2000-05-11 |
2005-05-24 |
Zymogenetics, Inc. |
Zsig33-like peptides
|
|
US20020061838A1
(en)
|
2000-05-17 |
2002-05-23 |
Barton Holmquist |
Peptide pharmaceutical formulations
|
|
ATE446758T1
(de)
|
2000-05-31 |
2009-11-15 |
Pfizer Prod Inc |
Verwendung von wachstumshormonsekretagoga zur förderung der beweglichkeit des verdauungstrakts
|
|
IL143690A0
(en)
|
2000-06-19 |
2002-04-21 |
Pfizer Prod Inc |
The use of growth hormone secretagogues to treat systemic lupus erythematosus and inflammatory bowel disease
|
|
IL143942A0
(en)
|
2000-06-29 |
2002-04-21 |
Pfizer Prod Inc |
Use of growth hormone secretagogues for treatment of physical performance decline
|
|
US7166712B2
(en)
|
2000-07-12 |
2007-01-23 |
Philadelphia, Health And Education Corporation |
Mammalian MDM2 binding proteins and uses thereof
|
|
IL144468A0
(en)
|
2000-07-27 |
2002-05-23 |
Pfizer Prod Inc |
Use of growth hormone secretagogues for improvement of functional health status
|
|
US7049290B2
(en)
|
2000-07-28 |
2006-05-23 |
Universität Zürich |
Essential downstream component of the wingless signaling pathway and therapeutic and diagnostic applications based thereon
|
|
US20030204063A1
(en)
|
2000-08-02 |
2003-10-30 |
Denis Gravel |
Modified biological peptides with increased potency
|
|
US20040228866A1
(en)
|
2000-08-04 |
2004-11-18 |
Ludwig Institute For Cancer Research |
Suppressor genes
|
|
AU2001284942A1
(en)
|
2000-08-16 |
2002-02-25 |
Georgetown University Medical Center |
Small molecule inhibitors targeted at bcl-2
|
|
IL145106A0
(en)
|
2000-08-30 |
2002-06-30 |
Pfizer Prod Inc |
Intermittent administration of a geowth hormone secretagogue
|
|
JP2004507502A
(ja)
|
2000-08-30 |
2004-03-11 |
ファイザー・プロダクツ・インク |
成長ホルモン分泌促進物質のための徐放性製剤
|
|
HUP0303854A2
(hu)
|
2000-09-08 |
2004-03-01 |
Gryhon Therapeutics, Inc. |
Szintetikus erythropoiesis-stimuláló proteinek
|
|
US6720330B2
(en)
|
2000-11-17 |
2004-04-13 |
Pfizer Inc. |
Somatostatin antagonists and agonists that act at the SST subtype 2 receptor
|
|
US20030074679A1
(en)
|
2000-12-12 |
2003-04-17 |
Schwartz Robert J. |
Administration of nucleic acid sequence to female animal to enhance growth in offspring
|
|
WO2002064790A2
(en)
|
2000-12-19 |
2002-08-22 |
The Johns Hopkins University |
Jfy1 protein induces rapid apoptosis
|
|
US20020091090A1
(en)
|
2000-12-28 |
2002-07-11 |
Cole Bridget M. |
Somatostatin antagonists and agonists
|
|
CU23157A1
(es)
|
2001-01-03 |
2006-07-18 |
Ct Ingenieria Genetica Biotech |
COMPOSICION FARMACéUTICA PARA EL TRATAMIENTO DEL DANO TISULAR DEBIDO A FALTA DE IRRIGACION SANGUINEA ARTERIAL
|
|
EA006484B1
(ru)
|
2001-02-02 |
2005-12-29 |
Конджачем, Инк. |
Долгоживущие производные рилизинг-фактора гормона роста
|
|
BR0207502A
(pt)
|
2001-02-23 |
2004-03-09 |
Polyphor Ltd |
Compostos, enanciÈmeros, composição farmacêutica, uso de compostos, e, processo para a fabricação de compostos
|
|
GB0104588D0
(en)
|
2001-02-24 |
2001-04-11 |
Univ Dundee |
Novel p-53 inducible protein
|
|
DE10109813A1
(de)
|
2001-03-01 |
2002-09-12 |
Thomas Stanislawski |
Tumor-Peptidantigen aus humanem mdm2 Proto-Onkogen
|
|
AU2002252246A1
(en)
|
2001-03-09 |
2002-09-24 |
University Of Louisville |
Helicomimetics and stabilized lxxll peptidomimetics
|
|
US7019109B2
(en)
|
2001-03-16 |
2006-03-28 |
The Salk Institute For Bilogical Studies |
SSTR1-selective analogs
|
|
WO2004037754A2
(en)
|
2002-10-24 |
2004-05-06 |
Dow Global Technologies Inc. |
Stabilization of olefin metathesis product mixtures
|
|
HUP0303727A2
(hu)
|
2001-04-09 |
2004-03-01 |
The Administrators Of The Tulane Educational Fund |
Szomatosztatin agonisták és ezek alkalmazása
|
|
US6368617B1
(en)
|
2001-05-15 |
2002-04-09 |
Reliv' International, Inc. |
Dietary supplement
|
|
AU2002312230A1
(en)
|
2001-06-05 |
2002-12-16 |
Elan Pharma International Limited |
System and method for milling materials
|
|
US20040248788A1
(en)
|
2001-07-06 |
2004-12-09 |
Vickers Mark Hedley |
Hypertenson treatment
|
|
JPWO2003014056A1
(ja)
|
2001-08-08 |
2004-11-25 |
鐘淵化学工業株式会社 |
光学活性２−置換カルボン酸の製造法
|
|
US20040106548A1
(en)
|
2001-09-07 |
2004-06-03 |
Schmidt Michelle A |
Conformationally constrained labeled peptides for imaging and therapy
|
|
EP1578901A4
(en)
|
2001-09-07 |
2006-03-29 |
Baylor College Medicine |
LINEAR DNA FRAGMENTS FOR GENE EXPRESSION
|
|
US20020045192A1
(en)
|
2001-09-19 |
2002-04-18 |
St. Jude Children's Research Hospital |
Arf and HDM2 interaction domains and methods of use thereof
|
|
EP1312363A1
(en)
|
2001-09-28 |
2003-05-21 |
Pfizer Products Inc. |
Methods of treatment and kits comprising a growth hormone secretagogue
|
|
PL195917B1
(pl)
*
|
2001-10-31 |
2007-11-30 |
Inst Farmaceutyczny |
Nowe peptydy - analogi ludzkiego hormonu uwalniającego hormon wzrostu
|
|
US20030083241A1
(en)
|
2001-11-01 |
2003-05-01 |
Young Charles W. |
Use of somatostatin receptor agonists in the treatment of human disorders of sleep hypoxia and oxygen deprivation
|
|
CN101157924A
(zh)
|
2001-12-11 |
2008-04-09 |
人体基因组科学有限公司 |
嗜中性白细胞因子α
|
|
AU2002351593A1
(en)
|
2001-12-18 |
2003-06-30 |
Theratechnologies Inc. |
Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses thereof
|
|
EP1321474A1
(en)
|
2001-12-18 |
2003-06-25 |
Universite De Geneve |
A method for inducing apoptosis
|
|
US20050043231A1
(en)
|
2001-12-24 |
2005-02-24 |
Cutfield Wayne Stephen |
Therapy for growth hormone induced insulin resistance in juveniles with growth disorders
|
|
US7247700B2
(en)
|
2001-12-31 |
2007-07-24 |
Dana Farber Cancer Institute, Inc. |
BID polypeptides and methods of inducing apoptosis
|
|
IL162604A0
(en)
|
2002-01-03 |
2005-11-20 |
Yissum Res Dev Co |
Conformationally constrained c-backbone cyclic peptides
|
|
ATE510919T1
(de)
|
2002-02-07 |
2011-06-15 |
Baylor College Medicine |
Veränderte hirnanhangsdrüsenentwicklung in nachkommen von mit einer therapie mit wachstumshormon freisetzendem hormon behandelten trächtigen muttertieren
|
|
WO2003068805A2
(en)
|
2002-02-14 |
2003-08-21 |
Bayer Pharmaceuticals Corporation |
Formulation strategies in stabilizing peptides in organic solvents and in dried states
|
|
AU2003211093A1
(en)
|
2002-02-15 |
2003-09-09 |
The Regents Of The University Of Michigan |
Inhibitors of rgs proteins
|
|
US20030166138A1
(en)
|
2002-02-21 |
2003-09-04 |
Todd Kinsella |
Cyclic peptides and analogs useful to treat allergies
|
|
WO2003081258A2
(en)
|
2002-03-26 |
2003-10-02 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor (ghs)
|
|
US7498134B2
(en)
|
2002-03-30 |
2009-03-03 |
The Trustees Of Columbia University In The City Of New York |
HAUSP-Mdm2 interaction and uses thereof
|
|
CN100419426C
(zh)
|
2002-04-22 |
2008-09-17 |
佛罗里达州立大学 |
功能化纳米微粒及其使用方法
|
|
US20060189511A1
(en)
|
2002-05-13 |
2006-08-24 |
Koblish Holly K |
Method for cytoprotection through mdm2 and hdm2 inhibition
|
|
KR101048279B1
(ko)
|
2002-05-30 |
2011-07-13 |
더 스크립스 리서치 인스티튜트 |
구리 촉매 작용하에서의 아지드와 아세틸렌과의 리게이션
|
|
WO2003102538A2
(en)
|
2002-05-30 |
2003-12-11 |
European Molecular Biology Laboratory |
Combinatorial chemical library ii
|
|
US7208154B2
(en)
|
2002-06-03 |
2007-04-24 |
Regents Of The University Of Michigan |
Methods and compositions for the treatment of MHC-associated conditions
|
|
SE0201863D0
(en)
|
2002-06-18 |
2002-06-18 |
Cepep Ab |
Cell penetrating peptides
|
|
US20040081652A1
(en)
|
2002-07-15 |
2004-04-29 |
The Johns Hopkins University |
Neuronal and optic nerve gene expression patterns
|
|
AU2003259172A1
(en)
|
2002-07-24 |
2004-02-09 |
The Salk Institute For Biological Studies |
Receptor (sstr4)- selective somatostatin analogs
|
|
TWI331922B
(en)
*
|
2002-08-09 |
2010-10-21 |
Ipsen Pharma Sas |
Growth hormone releasing peptides
|
|
AU2003261774A1
(en)
|
2002-09-06 |
2004-03-29 |
Kaneka Corporation |
PROCESS FOR PRODUCING L-Alpha-METHYLCYSTEINE DERIVATIVE
|
|
EP1590363A4
(en)
|
2002-09-09 |
2006-11-02 |
Dana Farber Cancer Inst Inc |
BH3-PEPTIDES AND METHOD FOR THEIR USE
|
|
CN1688696A
(zh)
|
2002-09-18 |
2005-10-26 |
蒙特利尔大学医疗中心 |
Ghrh类似物
|
|
WO2004026896A2
(en)
|
2002-09-23 |
2004-04-01 |
Medivir Ab |
Hcv ns-3 serine protease inhibitors
|
|
WO2004031229A2
(en)
|
2002-10-07 |
2004-04-15 |
Ludwig Institute For Cancer Research |
P53 binding polypeptide
|
|
US20040208866A1
(en)
|
2002-10-07 |
2004-10-21 |
Jaspers Stephen R. |
Methods of regulating body weight
|
|
EP1407779A1
(en)
|
2002-10-10 |
2004-04-14 |
Gastrotech A/S |
Use of ghrelin for treating low body weight and body fat in gastrectomized individuals
|
|
ES2336911T3
(es)
|
2002-11-07 |
2010-04-19 |
Kosan Biosciences, Inc. |
Trans-9,10-dehidroepotilonas c y d, sus analogos y procedimientos de preparacion.
|
|
KR100699614B1
(ko)
|
2002-11-08 |
2007-03-23 |
에프. 호프만-라 로슈 아게 |
퍼옥시좀 증식자 활성화된 수용체 작용제로서의 치환된4-알콕시옥사졸 유도체
|
|
US20050227932A1
(en)
|
2002-11-13 |
2005-10-13 |
Tianbao Lu |
Combinational therapy involving a small molecule inhibitor of the MDM2: p53 interaction
|
|
US7166575B2
(en)
|
2002-12-17 |
2007-01-23 |
Nastech Pharmaceutical Company Inc. |
Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesity
|
|
CA2511144A1
(en)
|
2002-12-20 |
2004-07-08 |
7Tm Pharma A/S |
Ghrelin receptor inverse agonist for regulation of feeding behaviours
|
|
US20070032417A1
(en)
|
2002-12-24 |
2007-02-08 |
Walter And Eliza Hall Institute Of Medical Research |
Peptides and therapeutic uses thereof
|
|
CA2512693A1
(en)
|
2003-01-08 |
2004-07-29 |
Xencor, Inc. |
Novel proteins with altered immunogenicity
|
|
US20040231909A1
(en)
|
2003-01-15 |
2004-11-25 |
Tai-Yang Luh |
Motorized vehicle having forward and backward differential structure
|
|
CA2513743C
(en)
|
2003-01-28 |
2013-06-25 |
Advisys, Inc. |
Reducing culling in herd animals growth hormone releasing hormone (ghrh)
|
|
WO2004067548A2
(en)
|
2003-01-31 |
2004-08-12 |
Theratechnologies Inc. |
Chemically modified metabolites of regulatory peptides and methods of producing and using same
|
|
WO2004073729A1
(ja)
|
2003-02-21 |
2004-09-02 |
Translational Research Ltd. |
薬物の経鼻投与用組成物
|
|
JPWO2004076483A1
(ja)
|
2003-02-26 |
2006-06-01 |
独立行政法人科学技術振興機構 |
癌細胞のアポトーシスを誘導する転写因子
|
|
EP1452868A2
(en)
|
2003-02-27 |
2004-09-01 |
Pepscan Systems B.V. |
Method for selecting a candidate drug compound
|
|
US20070060512A1
(en)
|
2003-03-04 |
2007-03-15 |
Homayoun Sadeghi |
Dipeptidyl-peptidase protected protein
|
|
WO2004084943A1
(en)
|
2003-03-19 |
2004-10-07 |
Beth Israel Deaconess Medical Center, Inc |
Use of antagonists of ghrelin or ghrelin receptor to treat intestinal inflammation
|
|
US7632920B2
(en)
|
2003-04-10 |
2009-12-15 |
Schering Corporation |
Soluble, stable form of HDM2, crystalline forms thereof and methods of use thereof
|
|
JP4879020B2
(ja)
|
2003-05-01 |
2012-02-15 |
コーネル リサーチ ファウンデイション インコーポレイテッド |
細胞に分子を送達する方法及び担体複合体
|
|
WO2004103390A2
(en)
|
2003-05-15 |
2004-12-02 |
Trustees Of Tufts College |
Stable analogs of peptide and polypeptide therapeutics
|
|
AU2003229222B2
(en)
|
2003-05-29 |
2009-11-12 |
Theratechnologies Inc. |
GRF analog compositions and their use
|
|
AU2003902743A0
(en)
|
2003-06-02 |
2003-06-19 |
Promics Pty Limited |
Process for the preparation of cyclic peptides
|
|
US20050031549A1
(en)
|
2003-06-09 |
2005-02-10 |
Nastech Pharmaceutical Company Inc. |
Compositions and methods for enhanced mucosal delivery of growth hormone
|
|
US7476653B2
(en)
|
2003-06-18 |
2009-01-13 |
Tranzyme Pharma, Inc. |
Macrocyclic modulators of the ghrelin receptor
|
|
WO2004111077A1
(en)
|
2003-06-18 |
2004-12-23 |
Tranzyme Pharma Inc. |
Macrocyclic antagonists of the motilin receptor
|
|
US7491695B2
(en)
|
2003-06-18 |
2009-02-17 |
Tranzyme Pharma Inc. |
Methods of using macrocyclic modulators of the ghrelin receptor
|
|
USRE42624E1
(en)
|
2003-06-18 |
2011-08-16 |
Tranzyme Pharma Inc. |
Methods of using macrocyclic modulators of the ghrelin receptor
|
|
US20090198050A1
(en)
|
2003-06-18 |
2009-08-06 |
Tranzyme Pharma Inc. |
Macrocyclic Modulators of the Ghrelin Receptor
|
|
USRE42013E1
(en)
|
2003-06-18 |
2010-12-28 |
Tranzyme Pharma Inc. |
Macrocyclic modulators of the ghrelin receptor
|
|
WO2005000876A2
(en)
|
2003-06-27 |
2005-01-06 |
Proteologics, Inc. |
Ring finger family proteins and uses related thereto
|
|
WO2005007675A2
(en)
|
2003-07-09 |
2005-01-27 |
The Scripps Research Institute |
TRIAZOLE ϵ-AMINO ACIDS
|
|
US20070185031A1
(en)
|
2003-07-14 |
2007-08-09 |
Northwestern University |
Reducing polyglutamine-based aggregation
|
|
GB0317815D0
(en)
|
2003-07-30 |
2003-09-03 |
Amersham Health As |
Imaging agents
|
|
EP1668116A4
(en)
|
2003-08-20 |
2007-08-15 |
Northern Sydney And Central Co |
METHOD FOR IMPROVING EMBRYOVIABILITY
|
|
WO2005018682A2
(en)
|
2003-08-20 |
2005-03-03 |
The Regents Of The University Of California |
Somatostatin analogs with inhibitory activity to growth hormone release
|
|
WO2005027913A1
(en)
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a growth hormone secretagogue
|
|
CN1859904A
(zh)
|
2003-10-03 |
2006-11-08 |
默克公司 |
用于治疗阿尔茨海默氏病的苄醚和苄氨基β－分泌酶抑制剂
|
|
CA2541090C
(en)
|
2003-10-03 |
2013-04-16 |
Veijlen N.V. |
Use of indole acetic acid or derivatives thereof to increase igf-1 serum levels
|
|
GB0323728D0
(en)
|
2003-10-10 |
2003-11-12 |
Royal College Of Surgeons Ie |
Peptidomimetics and uses thereof
|
|
EP1673386A2
(en)
|
2003-10-16 |
2006-06-28 |
AplaGen GmbH |
Stabilized alpha-helical peptides
|
|
US20070274915A1
(en)
|
2003-10-17 |
2007-11-29 |
Anjana Rao |
Modulation Of Anergy And Methods For isolating Anergy-Modulating Compounds
|
|
CA2542433A1
(en)
|
2003-10-20 |
2005-04-28 |
Theratechnologies Inc. |
Use of growth hormone releasing factor analogs in treating patients suffering from wasting
|
|
US7273927B2
(en)
|
2003-11-03 |
2007-09-25 |
University Of Massachusetts |
Mdm2 splice variants
|
|
SI1680443T1
(sl)
|
2003-11-05 |
2014-01-31 |
Dana-Farber Cancer Institute, Inc. |
Stabilizirani peptidi z alfa vijačnico in uporabe le-teh
|
|
US20050147581A1
(en)
|
2003-11-19 |
2005-07-07 |
The Board Of Trustees Of The University Of Illinois |
Macromolecular drug complexes having improved stability and therapeutic use of the same
|
|
WO2005074521A2
(en)
|
2004-01-30 |
2005-08-18 |
The Trustees Of Columbia University In The City Of New York |
C-TERMINAL p53 PALINDROMIC PEPTIDE THAT INDUCES APOPTOSIS OF CELLS WITH ABERRANT p53 AND USES THEREOF
|
|
US20070161551A1
(en)
|
2004-02-10 |
2007-07-12 |
De Luca Giampiero |
Methods and compositions for the treatment of lipodystrophy
|
|
GB0404731D0
(en)
|
2004-03-03 |
2004-04-07 |
Indp Administrative Inst Nims |
Method and products for the selective degradation of proteins
|
|
US20050203009A1
(en)
|
2004-03-12 |
2005-09-15 |
Bayer Pharmaceuticals Corporation |
VPAC1 selective antagonists and their pharmacological methods of use
|
|
EP1737884B1
(en)
|
2004-03-19 |
2016-10-19 |
The University Of Queensland |
Alpha helical mimics, their uses and methods for their production
|
|
WO2005097261A1
(en)
|
2004-03-30 |
2005-10-20 |
Sapphire Therapeutics, Inc. |
Method of reducing c-reactive protein using growth hormone secretagogues
|
|
CA2603295A1
(en)
|
2004-04-07 |
2006-10-20 |
Gastrotech Pharma A/S |
Use of ghrelin for the treatment of hyperthyroidism
|
|
US7034050B2
(en)
|
2004-04-28 |
2006-04-25 |
Romano Deghenghi |
Pseudopeptides growth hormone secretagogues
|
|
DE602005011132D1
(de)
|
2004-05-18 |
2009-01-02 |
Hoffmann La Roche |
Neuartige cis-imidazoline
|
|
WO2005118620A2
(en)
|
2004-05-27 |
2005-12-15 |
New York University |
Methods for preparing internally constraied peptides and peptidomimetics
|
|
US7501397B2
(en)
|
2004-06-04 |
2009-03-10 |
The Brigham And Women's Hospital, Inc. |
Helical peptidomimetics with enhanced activity
|
|
EP1602663A1
(en)
|
2004-06-04 |
2005-12-07 |
Chiralix B.V. |
Triazole-linked glycoamino acids and glycopeptides
|
|
CN100335467C
(zh)
|
2004-06-04 |
2007-09-05 |
中国科学院上海有机化学研究所 |
一锅法区域选择性合成5－碘代－1，4－二取代－1，2，3－三氮唑化合物
|
|
US7893278B2
(en)
|
2004-06-17 |
2011-02-22 |
Hoffman-La Roche Inc. |
CIS-imidazolines
|
|
US7842815B2
(en)
|
2004-06-17 |
2010-11-30 |
Infinity Pharmaceuticals, Inc. |
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
|
|
CN102603895B
(zh)
|
2004-06-18 |
2016-09-28 |
Ambrx公司 |
新颖抗原结合多肽和其用途
|
|
US7674787B2
(en)
|
2004-07-09 |
2010-03-09 |
The Regents Of The University Of Michigan |
Conformationally constrained Smac mimetics and the uses thereof
|
|
US8039456B2
(en)
|
2004-08-12 |
2011-10-18 |
Helsinn Therapeutics (U.S.), Inc. |
Method of stimulating the motility of the gastrointestinal system using ipamorelin
|
|
KR101380200B1
(ko)
|
2004-08-12 |
2014-04-01 |
헬신 세라퓨틱스 (유.에스.) 인크. |
성장 호르몬 분비촉진제를 이용하여 위장관계의 운동성을촉진하는 방법
|
|
EP2389941A1
(en)
|
2004-08-18 |
2011-11-30 |
Elixir Pharmaceuticals, Inc. |
Growth-hormone secretagogues
|
|
US7074775B2
(en)
|
2004-09-14 |
2006-07-11 |
Miller Landon C G |
Aminobutyramide conjugate and a pharmaceutical composition for treatment of neuronal disorders
|
|
US7151084B2
(en)
|
2004-12-27 |
2006-12-19 |
Miller Landon C G |
Compound and method of treating neurogenic conditions using non-steroidal anti-inflammatory drug complexes
|
|
US7402652B2
(en)
|
2004-09-14 |
2008-07-22 |
Miller Landon C G |
Baclofen conjugate and a pharmaceutical composition for treatment of neuronal disorders
|
|
US7157421B2
(en)
|
2004-12-27 |
2007-01-02 |
Miller Landon C G |
Piracetam and piracetam analog conjugate and a pharmaceutical composition for treatment of neuronal disorders
|
|
US9598470B2
(en)
|
2004-10-07 |
2017-03-21 |
Craig W. Beattie |
Compositions and methods to prevent cancer by stabilizing P53 through non MDM2-mediated pathways
|
|
EP1812048A4
(en)
|
2004-10-20 |
2012-01-18 |
Theratechnologies Inc |
GH SECRETAGOGA AND ITS USE
|
|
ATE432922T1
(de)
|
2004-10-29 |
2009-06-15 |
Schering Corp |
Substituierte 5-carboxyamidpyrazoles und ä1,2, 4ütriazole als viruzide
|
|
US7998930B2
(en)
|
2004-11-04 |
2011-08-16 |
Hanall Biopharma Co., Ltd. |
Modified growth hormones
|
|
WO2006069001A2
(en)
|
2004-12-20 |
2006-06-29 |
Baylor College Of Medicine |
Structural requirements for stat3 binding and recruitment to phosphototyrosine ligands
|
|
GB0428187D0
(en)
|
2004-12-23 |
2005-01-26 |
Univ Liverpool |
Cancer treatment
|
|
CA2595902C
(en)
|
2005-01-24 |
2017-08-22 |
Pepscan Systems B.V. |
Binding compounds, immunogenic compounds and peptidomimetics of the beta-3 hairpin loop of cystine-knot growth factors
|
|
FR2881430B1
(fr)
|
2005-02-01 |
2010-10-22 |
Servier Lab |
Nouveaux peptides interagissant avec les membres anti-apoptotiques de la famille de proteines bcl-2 et utilisations
|
|
SG176463A1
(en)
|
2005-02-22 |
2011-12-29 |
Univ Michigan |
Small molecule inhibitors of mdm2 and uses thereof
|
|
JP2008535486A
(ja)
|
2005-03-15 |
2008-09-04 |
アラーガン、インコーポレイテッド |
クロストリジウム毒素標的細胞に対する改変された標的能力を有する修飾クロストリジウム毒素
|
|
WO2006103666A2
(en)
|
2005-03-28 |
2006-10-05 |
Yeda Research And Development Co. Ltd. |
Isolated bid polypeptides, polynucleotides encoding same and antibodies directed thereagainst and methods of using same for inducing cell cycle arrest or apoptosis
|
|
WO2006122931A1
(en)
|
2005-05-20 |
2006-11-23 |
Biovitrum Ab (Publ) |
Beta-carboline derivatives and theri use as ghsr modulators
|
|
US20090275648A1
(en)
|
2005-06-13 |
2009-11-05 |
Fraser Graeme L |
Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same
|
|
WO2006137974A2
(en)
|
2005-06-13 |
2006-12-28 |
Tranzyme Pharma, Inc. |
Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same
|
|
US20070020620A1
(en)
|
2005-07-14 |
2007-01-25 |
Finn M G |
Compositions and methods for coupling a plurality of compounds to a scaffold
|
|
US20090311174A1
(en)
|
2005-07-21 |
2009-12-17 |
Barry John Allen |
Method For Treating Cancer
|
|
US8138218B2
(en)
|
2005-07-22 |
2012-03-20 |
Ipsen Pharma S.A.S. |
Growth hormone secretagogues
|
|
EP1757290A1
(en)
|
2005-08-16 |
2007-02-28 |
Zentaris GmbH |
Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors
|
|
WO2007038678A2
(en)
|
2005-09-28 |
2007-04-05 |
Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. |
Analogs of ghrelin
|
|
US20070161544A1
(en)
|
2006-01-06 |
2007-07-12 |
Peter Wipf |
Selective targeting agents for mitcochondria
|
|
EP1986673A2
(en)
|
2006-02-13 |
2008-11-05 |
The Government Of The Usa As Represented By The Secretary Of The Dept. Of Health and Human Services |
Methods and compositions related to ghs-r antagonists
|
|
US7745573B2
(en)
|
2006-02-17 |
2010-06-29 |
Polychip Pharmaceuticals Pty Ltd. |
Conotoxin analogues and methods for synthesis of intramolecular dicarba bridge-containing peptides
|
|
US7538190B2
(en)
|
2006-02-17 |
2009-05-26 |
Polychip Pharmaceuticals Pty Ltd |
Methods for the synthesis of two or more dicarba bridges in organic compounds
|
|
GB0603295D0
(en)
|
2006-02-18 |
2006-03-29 |
Ardana Bioscience Ltd |
Methods and kits
|
|
CU23592A1
(es)
|
2006-02-28 |
2010-11-11 |
Ct Ingenieria Genetica Biotech |
Método para prevenir y eliminar las fibrosis y otras formas de depósito patológico en los tejidos aplicando el péptido secretagogo ghrp-6
|
|
NZ571183A
(en)
|
2006-03-13 |
2010-09-30 |
Liat Mintz |
Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite stimulation
|
|
EP2007716A1
(en)
|
2006-04-13 |
2008-12-31 |
Glaxo Group Limited |
Aryl and heteroaryl sulphonamides as growth hormone secretagogue receptor agonists
|
|
EP2021015A2
(en)
|
2006-04-28 |
2009-02-11 |
The Administrators Of The Tulane Educational Fund |
Ghrelin/growth hormone releasing peptide/growth hormone secretatogue receptor antagonists and uses thereof
|
|
GB0611405D0
(en)
|
2006-06-09 |
2006-07-19 |
Univ Belfast |
FKBP-L: A novel inhibitor of angiogenesis
|
|
US7998927B2
(en)
|
2006-06-23 |
2011-08-16 |
Aegis Therapeutics, Llc |
Stabilizing alkylglycoside compositions and methods thereof
|
|
US8084022B2
(en)
|
2006-06-23 |
2011-12-27 |
Aegis Therapeutics, Llc |
Stabilizing alkylglycoside compositions and methods thereof
|
|
US20090326193A1
(en)
|
2006-06-23 |
2009-12-31 |
Aegis Therapeutics Llc |
Stabilizing alkylglycoside compositions and methods thereof
|
|
US7425542B2
(en)
|
2006-06-23 |
2008-09-16 |
Aegis Therapeutics, Inc. |
Stabilizing alkylglycoside compositions and methods thereof
|
|
US8173594B2
(en)
|
2006-06-23 |
2012-05-08 |
Aegis Therapeutics, Llc |
Stabilizing alkylglycoside compositions and methods thereof
|
|
US8226949B2
(en)
|
2006-06-23 |
2012-07-24 |
Aegis Therapeutics Llc |
Stabilizing alkylglycoside compositions and methods thereof
|
|
MX2009000285A
(es)
|
2006-06-30 |
2009-06-08 |
Schering Corp |
Piperidinas sustituidas que incrementan la actividad de p53 y usos de las mismas.
|
|
US20080004286A1
(en)
|
2006-06-30 |
2008-01-03 |
Schering Corporation |
Method of Using Substituted Piperidines that Increase P53 Activity
|
|
US8088733B2
(en)
|
2006-07-06 |
2012-01-03 |
Tranzyme Pharma Inc. |
Methods of using macrocyclic agonists of the ghrelin receptor for treatment of gastrointestinal motility disorders
|
|
US20080015265A1
(en)
|
2006-07-11 |
2008-01-17 |
Byron Rubin |
Methods of treating obesity using satiety factors
|
|
NZ574423A
(en)
|
2006-07-26 |
2012-04-27 |
Pepscan Systems Bv |
Immunogenic compounds and protein mimics
|
|
US8614192B2
(en)
|
2006-07-28 |
2013-12-24 |
Leiden University Medical Center |
Method for treating ocular cancer
|
|
US7737174B2
(en)
|
2006-08-30 |
2010-06-15 |
The Regents Of The University Of Michigan |
Indole inhibitors of MDM2 and the uses thereof
|
|
EP2099445B1
(en)
|
2006-09-04 |
2010-11-17 |
University Court of The University of Dundee |
P53 activating benzoyl urea and benzoyl thiourea compounds
|
|
US20080213175A1
(en)
|
2006-09-15 |
2008-09-04 |
Kolb Hartmuth C |
Click chemistry-derived cyclic peptidomimetics as integrin markers
|
|
MX2009002735A
(es)
|
2006-09-21 |
2009-05-08 |
Hoffmann La Roche |
Derivados de oxindol como agentes anticancerigenos.
|
|
US7897394B2
(en)
|
2006-09-21 |
2011-03-01 |
Intrexon Corporation |
Endoplasmic reticulum localization signals
|
|
US8299022B2
(en)
|
2006-09-27 |
2012-10-30 |
Ipsen Pharma S.A.S. |
Analogs of ghrelin substituted at the N-terminal
|
|
CN101516361A
(zh)
|
2006-09-28 |
2009-08-26 |
亚瑞特医疗公司 |
可溶性环氧化物水解酶抑制剂
|
|
CA2665186A1
(en)
|
2006-10-05 |
2008-04-17 |
New York Blood Center, Inc. |
Stabilized therapeutic small helical antiviral peptides
|
|
KR100860060B1
(ko)
|
2006-10-12 |
2008-09-24 |
한국과학기술연구원 |
ＨＩＦ-１α Ｃ-말단 펩타이드와 ＣＢＰ 또는 ｐ３００단백질과의 결합을 정량분석하는 방법 및 상기 방법을이용한 단백질 복합체 형성을 저해하는 억제제의 스크리닝방법
|
|
US8691761B2
(en)
|
2006-10-16 |
2014-04-08 |
Jean E. F. Rivier |
Somatostatin receptor 2 antagonists
|
|
EP2433963B1
(en)
|
2006-10-16 |
2014-06-04 |
The Salk Institute for Biological Studies |
Receptor (SSTR2)-selective somatostatin antagonists
|
|
CA2669696A1
(en)
|
2006-11-15 |
2008-05-22 |
Dana-Farber Cancer Institute, Inc. |
Stabilized maml peptides and uses thereof
|
|
US7932397B2
(en)
|
2006-11-22 |
2011-04-26 |
Massachusetts Institute Of Technology |
Olefin metathesis catalysts and related methods
|
|
EP3170835A1
(en)
|
2006-12-14 |
2017-05-24 |
Aileron Therapeutics, Inc. |
Bis-sulfhydryl macrocyclization systems
|
|
US7981998B2
(en)
|
2006-12-14 |
2011-07-19 |
Aileron Therapeutics, Inc. |
Bis-sulfhydryl macrocyclization systems
|
|
CA2672826A1
(en)
|
2006-12-21 |
2008-06-26 |
Cytos Biotechnology Ag |
Circular ccr5 peptide conjugates and uses thereof
|
|
US8633163B2
(en)
|
2007-01-29 |
2014-01-21 |
Polyphor Ltd. |
Template-fixed peptidomimetics
|
|
DK2118123T3
(en)
|
2007-01-31 |
2016-01-25 |
Dana Farber Cancer Inst Inc |
Stabilized p53 peptides and uses thereof
|
|
ES2604943T3
(es)
|
2007-02-09 |
2017-03-10 |
Ocera Therapeutics, Inc. |
Moduladores macrocíclicos del receptor de la grelina y procedimientos de uso de los mismos
|
|
CN101244053B
(zh)
|
2007-02-16 |
2010-12-08 |
石药集团中奇制药技术（石家庄）有限公司 |
以多西他赛为主组分的新的分散体系
|
|
EP2114428B1
(en)
|
2007-02-23 |
2012-10-31 |
Aileron Therapeutics, Inc. |
Triazole linked macrocyclic peptides
|
|
WO2008106507A2
(en)
|
2007-02-27 |
2008-09-04 |
University Of South Florida |
Mdm2/mdmx inhibitor peptide
|
|
WO2008112939A2
(en)
|
2007-03-13 |
2008-09-18 |
Board Of Regents, The University Of Texas System |
Composition and method for making oligo-benzamide compounds
|
|
EP3159352B1
(en)
|
2007-03-28 |
2023-08-02 |
President and Fellows of Harvard College |
Stitched polypeptides
|
|
TWI429436B
(zh)
|
2007-04-10 |
2014-03-11 |
Helsinn Therapeutics Us Inc |
使用生長激素促泌素治療或預防嘔吐之方法
|
|
US20080260820A1
(en)
|
2007-04-19 |
2008-10-23 |
Gilles Borrelly |
Oral dosage formulations of protease-resistant polypeptides
|
|
EP2152294B1
(en)
|
2007-05-02 |
2017-07-26 |
Dana-Farber Cancer Institute, Inc. |
A bad bh3 domain peptide for use in treating or delaying the onset of diabetes.
|
|
MX2009012964A
(es)
|
2007-06-01 |
2010-01-14 |
Acologix Inc |
Formulacion de peptido estable a alta temperatura.
|
|
WO2009009727A2
(en)
|
2007-07-12 |
2009-01-15 |
Akela Pharma Srl |
Ghrh analogs and therapeutic uses thereof
|
|
RU2007133287A
(ru)
|
2007-09-05 |
2009-03-10 |
Ионов Иль Давидович (RU) |
Противопсориатическое средство и способ его применения (варианты)
|
|
CA2699078A1
(en)
|
2007-09-11 |
2009-04-09 |
Dorian Bevec |
Use of grf-1 (1-29 ) and corticotropin-releasing factor as therapeutic agents
|
|
WO2009046850A1
(en)
|
2007-09-11 |
2009-04-16 |
Mondobiotech Laboratories Ag |
Cgrp as a therapeutic agent
|
|
WO2009033732A2
(en)
|
2007-09-11 |
2009-03-19 |
Mondobiotech Laboratories Ag |
Use of the peptide phpfhlfvy (renin inhibitor) as a therapeutic agent
|
|
EP2197431A4
(en)
|
2007-09-17 |
2013-03-27 |
Olas Pharmaceuticals Inc |
MODULATION OF GROWTH HORMONE, DHEA AND CORTISOL USING POSITIVE MODULATORS OF AMPA-TYPE GLUTAMATE RECEPTORS
|
|
US8288377B2
(en)
|
2007-09-21 |
2012-10-16 |
Janssen Pharmaceutica N.V. |
Inhibitors of the interaction between MDM2 and p53
|
|
CA2700925C
(en)
|
2007-09-26 |
2016-08-23 |
Dana Farber Cancer Institute |
Methods and compositions for modulating bcl-2 family polypeptides
|
|
CA2605036A1
(en)
|
2007-10-01 |
2009-04-01 |
Centre Hospitalier De L'universite De Montreal (Chum) |
Renoprotection by growth hormone-releasing hormone and agonists
|
|
KR101500528B1
(ko)
|
2007-12-03 |
2015-03-09 |
이탈파마코 에스.피.에이. |
새로운 비-선택적 소마토스타틴 유사체
|
|
EP2247298B1
(en)
|
2007-12-31 |
2016-08-31 |
New York University |
Control of viral-host membrane fusion with hydrogen bond surrogate-based artificial helices
|
|
AU2009204501B2
(en)
|
2008-01-07 |
2015-02-12 |
Amgen Inc. |
Method for making antibody Fc-heterodimeric molecules using electrostatic steering effects
|
|
US9687834B2
(en)
|
2008-01-25 |
2017-06-27 |
Trustees Of Boston College |
Catalysts for metathesis reactions including enantioselective olefin metathesis, and related methods
|
|
MX356866B
(es)
|
2008-01-25 |
2018-06-18 |
Multivir Inc |
Biomarcadores p53.
|
|
DE112009000300T5
(de)
|
2008-02-08 |
2011-01-20 |
Aileron Therapeutics, Inc., Cambridge |
Therapeutische Peptidomimetische Makrocyclen
|
|
US20110144303A1
(en)
*
|
2008-04-08 |
2011-06-16 |
Aileron Therapeutics, Inc. |
Biologically Active Peptidomimetic Macrocycles
|
|
US20090326192A1
(en)
|
2008-04-08 |
2009-12-31 |
Aileron Therapeutics, Inc. |
Biologically active peptidomimetic macrocycles
|
|
JP2011522796A
(ja)
|
2008-05-06 |
2011-08-04 |
ニューヨーク ブラッド センター， インコーポレイテッド |
抗ウイルス細胞透過性ペプチド
|
|
EP2285970A4
(en)
|
2008-06-03 |
2011-10-12 |
Aileron Therapeutics Inc |
COMPOSITIONS AND METHODS FOR REINFORCING THE CELL TRANSPORT OF BIOMOLECULES
|
|
WO2009149339A2
(en)
|
2008-06-05 |
2009-12-10 |
University Of Maryland, Baltimore |
P53 activator peptides
|
|
EP3473643A1
(en)
|
2008-06-12 |
2019-04-24 |
Ipsen Bioinnovation Limited |
Fusion proteins for use in the treatemnt of cancer
|
|
US20110158973A1
(en)
|
2008-06-12 |
2011-06-30 |
Syntaxin Limited |
Suppression of cancers
|
|
ES2750651T3
(es)
|
2008-06-12 |
2020-03-26 |
Ipsen Bioinnovation Ltd |
Proteínas de fusión para uso en el tratamiento de acromegalia
|
|
US8796216B2
(en)
|
2008-06-12 |
2014-08-05 |
Syntaxin Limited |
Suppression of neuroendocrine diseases
|
|
JP5627581B2
(ja)
|
2008-06-25 |
2014-11-19 |
ブラーシュ・バイオテック・エルエルシー |
ソマトスタチン免疫原性増進のための組成物および方法
|
|
US20110144306A1
(en)
|
2008-07-23 |
2011-06-16 |
President And Fellows Of Harvard College |
Ligation of stapled polypeptides
|
|
GB0813873D0
(en)
|
2008-07-30 |
2008-09-03 |
Univ Dundee |
Compounds
|
|
US8583380B2
(en)
|
2008-09-05 |
2013-11-12 |
Aueon, Inc. |
Methods for stratifying and annotating cancer drug treatment options
|
|
US8586707B2
(en)
|
2008-09-16 |
2013-11-19 |
The Research Foundation Of State University Of New York |
Stapled peptides and method of synthesis
|
|
AU2009293020A1
(en)
|
2008-09-18 |
2010-03-25 |
New York University |
Inhibiting interaction between HIF-1a and p300/CBP with hydrogen bond surrogate-based helices
|
|
WO2010033240A2
(en)
|
2008-09-19 |
2010-03-25 |
Nektar Therapeutics |
Carbohydrate-based drug delivery polymers and conjugates thereof
|
|
CA2737921C
(en)
|
2008-09-22 |
2019-01-15 |
Aileron Therapeutics, Inc. |
Methods for preparing purified alpha-helical peptidomimetic macrocycle compositions with low metal ppm levels
|
|
EP2342214A1
(en)
|
2008-09-22 |
2011-07-13 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
CN102884074A
(zh)
|
2008-09-22 |
2013-01-16 |
爱勒让治疗公司 |
拟肽大环化合物
|
|
CA2737914A1
(en)
|
2008-09-22 |
2010-03-25 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
US20120115793A1
(en)
|
2008-09-22 |
2012-05-10 |
Alleron therapeutics, Inc |
Peptidomimetic macrocycles
|
|
JP5711128B2
(ja)
|
2008-09-22 |
2015-04-30 |
エルロン・セラピューティクス・インコーポレイテッドＡｉｌｅｒｏｎ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
ペプチド模倣大環状分子
|
|
EP3401684B1
(en)
|
2008-10-10 |
2022-03-16 |
Dana Farber Cancer Institute, Inc. |
Chemical modulators of pro-apoptotic bax and bcl-2 polypeptides
|
|
JP2010120881A
(ja)
|
2008-11-19 |
2010-06-03 |
Keio Gijuku |
ヒト癌タンパク質ＭＤＭ２とヒト癌抑制タンパク質ｐ５３との相互作用阻害ペプチド及びその使用
|
|
KR101298168B1
(ko)
|
2008-11-21 |
2013-08-20 |
충남대학교산학협력단 |
스네일―ｐ５３ 간의 결합을 저해하는 화합물 및 이를 유효성분으로 함유하는 암질환 치료제
|
|
AU2009316288B2
(en)
|
2008-11-24 |
2016-05-19 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles with improved properties
|
|
WO2010065572A1
(en)
|
2008-12-04 |
2010-06-10 |
The Salk Institute For Biological Studies |
Sstr1-selective analogs
|
|
US9079970B2
(en)
|
2008-12-09 |
2015-07-14 |
Dana Farber Cancer Institute, Inc. |
Methods and compositions for specific modulation of MCL-1
|
|
US20100152114A1
(en)
|
2008-12-12 |
2010-06-17 |
Univ Of Miami And Usa By Dept Of Veterans Affairs |
Antioxidant activity of GH-RH Antagonists
|
|
EP2376100B1
(en)
|
2009-01-14 |
2017-10-25 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
WO2010083501A2
(en)
|
2009-01-16 |
2010-07-22 |
University Of South Florida |
Alpha-helix mimetic using a 2,5-oligopyrimidine scaffold
|
|
US8217051B2
(en)
|
2009-02-17 |
2012-07-10 |
Hoffmann-La Roche Inc. |
Spiroindolinone derivatives
|
|
US20100239589A1
(en)
|
2009-02-23 |
2010-09-23 |
Salk Institute For Biological Studies |
Methods and Compositions for Ameliorating Diabetes and Symptoms Thereof
|
|
FR2942798B1
(fr)
|
2009-03-05 |
2011-04-08 |
Centre Nat Rech Scient |
Peptides utilisables pour le traitement de la leucemie lymphoide chronique
|
|
US20120135089A1
(en)
|
2009-03-17 |
2012-05-31 |
Stockwell Brent R |
E3 ligase inhibitors
|
|
EP2421548A4
(en)
|
2009-04-20 |
2012-09-26 |
Theratechnologies Inc |
USE OF (HEXENOYL TRANS-3) HGRF (1-44) NH2 AND SIMVASTATIN IN COMBINED TREATMENT
|
|
CN102460175B
(zh)
|
2009-04-22 |
2014-09-10 |
沃尔特及伊莱萨霍尔医学研究院 |
胰岛素受体α-链以及胰岛素样生长因子受体α-链的C末端区域的结构
|
|
US8076482B2
(en)
|
2009-04-23 |
2011-12-13 |
Hoffmann-La Roche Inc. |
3,3′-spiroindolinone derivatives
|
|
US8883721B2
(en)
|
2009-05-12 |
2014-11-11 |
Mcgill University |
Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof
|
|
US20100303794A1
(en)
|
2009-05-29 |
2010-12-02 |
Allergan, Inc. |
Methods of Treating Urogenital-Neurological Disorders Using Glucagon Like Hormone Retargeted Endopepidases
|
|
US20100303791A1
(en)
|
2009-05-29 |
2010-12-02 |
Allergan, Inc. |
Methods of Treating Chronic Neurogenic Inflammation Using Glucagon Like Hormone Retargeted Endopepidases
|
|
WO2011005219A1
(en)
|
2009-07-07 |
2011-01-13 |
Agency For Science, Technology And Research |
Novel mdm2 binding peptides and uses thereof
|
|
EP2453908B1
(en)
|
2009-07-13 |
2018-03-14 |
President and Fellows of Harvard College |
Bifunctional stapled polypeptides and uses thereof
|
|
KR20120050492A
(ko)
|
2009-08-26 |
2012-05-18 |
노파르티스 아게 |
테트라-치환된 헤테로아릴 화합물 및 ｍｄｍ2 및/또는 ｍｄｍ4 조절제로서의 그의 용도
|
|
CA2774973A1
(en)
*
|
2009-09-22 |
2011-03-31 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
US20110245159A1
(en)
|
2009-09-30 |
2011-10-06 |
Hoveyda Hamid R |
Salts, Solvates and Pharmaceutical Compositions of Macrocyclic Ghrelin Receptor Agonists and Methods of Using the Same
|
|
CN102655875A
(zh)
|
2009-10-14 |
2012-09-05 |
爱勒让治疗公司 |
改善的拟肽大环化合物
|
|
US8017607B2
(en)
|
2009-10-14 |
2011-09-13 |
Hoffmann-La Roche Inc. |
N-substituted-pyrrolidines as inhibitors of MDM2-P-53 interactions
|
|
CA2778990A1
(en)
|
2009-10-30 |
2011-05-05 |
Tranzyme Pharma, Inc. |
Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same
|
|
RU2576512C2
(ru)
|
2009-11-04 |
2016-03-10 |
Хэлс Ресеч Инк. |
Способ и композиции для подавления старения
|
|
EP2499145B1
(en)
|
2009-11-12 |
2016-01-27 |
The Regents Of The University Of Michigan |
Spiro-oxindole mdm2 antagonists
|
|
US20110118283A1
(en)
|
2009-11-17 |
2011-05-19 |
Qingjie Ding |
Substituted Pyrrolidine-2-Carboxamides
|
|
US8088815B2
(en)
|
2009-12-02 |
2012-01-03 |
Hoffman-La Roche Inc. |
Spiroindolinone pyrrolidines
|
|
CU24130B1
(es)
|
2009-12-22 |
2015-09-29 |
Novartis Ag |
Isoquinolinonas y quinazolinonas sustituidas
|
|
US8440693B2
(en)
|
2009-12-22 |
2013-05-14 |
Novartis Ag |
Substituted isoquinolinones and quinazolinones
|
|
US8658170B2
(en)
|
2010-01-06 |
2014-02-25 |
Joseph P. Errico |
Combination therapy with MDM2 and EFGR inhibitors
|
|
KR101220516B1
(ko)
|
2010-01-21 |
2013-01-10 |
연세대학교 산학협력단 |
항－ｍｄｍ２를 발현하는 인간 성체줄기세포 및 그의 용도
|
|
US8598400B2
(en)
|
2010-02-08 |
2013-12-03 |
Massachusetts Institute Of Technology |
Efficient methods for Z- or cis-selective cross-metathesis
|
|
US8288431B2
(en)
|
2010-02-17 |
2012-10-16 |
Hoffmann-La Roche Inc. |
Substituted spiroindolinones
|
|
WO2011106650A2
(en)
|
2010-02-27 |
2011-09-01 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Novel p53-mdm2/p53-mdm4 antagonists to treat proliferative disease
|
|
RU2012147597A
(ru)
|
2010-04-09 |
2014-05-20 |
Дзе Риджентс Оф Дзе Юниверсити Оф Мичиган |
Биомаркеры для ингибиторов mdm2, использующиеся для лечения заболевания
|
|
WO2011133948A2
(en)
|
2010-04-22 |
2011-10-27 |
Longevity Biotech, Inc. |
Highly active polypeptides and methods of making and using the same
|
|
CN103079587B
(zh)
|
2010-05-13 |
2016-05-11 |
印第安纳大学研究及科技有限公司 |
呈现核激素受体活性的胰高血糖素超家族肽
|
|
EP2568993A4
(en)
|
2010-05-13 |
2014-02-19 |
Univ Indiana Res & Tech Corp |
GLUCAGON SUPERFAMILY PEPTIDES WITH G-PROTEIN-COUPLED RECEPTOR ACTIVITY
|
|
US8980249B2
(en)
|
2010-06-03 |
2015-03-17 |
University Of Miami |
Agonists of growth hormone releasing hormone as effectors for survival and proliferation of pancreatic islets
|
|
EP2582715B1
(en)
|
2010-06-16 |
2018-11-28 |
The Administrators of the Tulane Educational Fund |
Growth hormone secretatogue receptor antagonists and uses thereof
|
|
US20110313167A1
(en)
|
2010-06-22 |
2011-12-22 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Substituted Heterocycles as Therapeutic agents for treating cancer
|
|
US20130177979A1
(en)
|
2010-06-22 |
2013-07-11 |
University Of Central Florida Research Foundation, Inc. |
Methods and compositions for cell permeable stat3 inhibitor
|
|
RU2013102991A
(ru)
|
2010-06-24 |
2014-08-10 |
Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн |
Связанные с дипептидом лекарственные средства
|
|
WO2011163012A2
(en)
|
2010-06-24 |
2011-12-29 |
Indiana University Research And Technology Corporation |
Amide based glucagon superfamily peptide prodrugs
|
|
US8907053B2
(en)
|
2010-06-25 |
2014-12-09 |
Aurigene Discovery Technologies Limited |
Immunosuppression modulating compounds
|
|
WO2012012352A2
(en)
|
2010-07-19 |
2012-01-26 |
Amidebio, Llc |
Modified peptides and proteins
|
|
WO2012016186A1
(en)
|
2010-07-29 |
2012-02-02 |
President And Fellows Of Harvard College |
Macrocyclic kinase inhibitors and uses thereof
|
|
SI2603600T1
(sl)
|
2010-08-13 |
2019-04-30 |
Aileron Therapeutics, Inc. |
Peptidomimetični makrocikli
|
|
JP2013537191A
(ja)
|
2010-09-08 |
2013-09-30 |
ユニバーシティー オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケーション |
ｐ５３−Ｍｄｍ２アンタゴニスト
|
|
US20120065210A1
(en)
|
2010-09-15 |
2012-03-15 |
Xin-Jie Chu |
Substituted hexahydropyrrolo[1,2-c]imidazolones
|
|
EP2431035A1
(en)
|
2010-09-16 |
2012-03-21 |
Æterna Zentaris GmbH |
Novel Triazole Derivatives with Improved Receptor Activity and Bioavailability Properties as Ghrelin Antagonists of Growth Hormone Secretagogue Receptors
|
|
EP2616095A4
(en)
|
2010-09-16 |
2014-03-19 |
Univ Miami |
WOUND HEALING ACCELERATION BY A GROWTH HORMONE RELEASING HORMON AND HIS AGONISTS
|
|
CN102399284B
(zh)
|
2010-09-17 |
2013-05-29 |
中国农业大学 |
狐狸生长激素释放激素cDNA及其应用
|
|
CN102399283B
(zh)
|
2010-09-17 |
2013-05-29 |
中国农业大学 |
水貂生长激素释放激素cDNA及其应用
|
|
US20120071499A1
(en)
|
2010-09-20 |
2012-03-22 |
Xin-Jie Chu |
Substituted Spiro[3H-Indole-3,6'(5'H)-[1H]Pyrrolo[1,2c]Imidazole-1',2(1H,2'H)-diones
|
|
WO2012040459A2
(en)
|
2010-09-22 |
2012-03-29 |
President And Fellows Of Harvard College |
Beta-catenin targeting peptides and uses thereof
|
|
US20130225603A1
(en)
|
2010-09-27 |
2013-08-29 |
Serrata Llc |
Mdm2 inhibitors for treatment of ocular conditions
|
|
ES2685175T3
(es)
|
2010-09-30 |
2018-10-05 |
St. Jude Children's Research Hospital |
Imidazoles sustituidos con arilo
|
|
EP2627662B1
(en)
|
2010-10-13 |
2015-09-16 |
Bristol-Myers Squibb Company |
Methods for preparing macrocycles and macrocycle stabilized peptides
|
|
FR2967072B1
(fr)
|
2010-11-05 |
2013-03-29 |
Univ Dundee |
Procede pour ameliorer la production de virus et semences vaccinales influenza
|
|
UY33725A
(es)
|
2010-11-12 |
2012-06-29 |
Sanofi Sa |
Antagonistas de mdm2 de espiro-oxindol
|
|
CA2817568A1
(en)
|
2010-11-12 |
2012-05-18 |
The Salk Institute For Biological Studies Intellectual Property And Tech Nology Transfer |
Cancer therapies and diagnostics
|
|
WO2012076513A1
(en)
|
2010-12-09 |
2012-06-14 |
F. Hoffmann-La Roche Ag |
3-cyano-1-hydroxymethyl-2-phenylpyrrolidine derivatives as inhibitors of mdm2-p53 interactions useful for the treatment of cancer
|
|
US9029332B2
(en)
|
2010-12-15 |
2015-05-12 |
The Research Foundation For The State University Of New York |
Cross-linked peptides and proteins, methods of making same, and uses thereof
|
|
EP2651976A1
(en)
|
2010-12-16 |
2013-10-23 |
Roche Glycart AG |
Combination therapy of an afucosylated cd20 antibody with a mdm2 inhibitor
|
|
WO2012083181A1
(en)
|
2010-12-16 |
2012-06-21 |
Indiana University Research And Technology Corporation |
Alpha helix mimetics and methods for using
|
|
CN103261188A
(zh)
|
2010-12-17 |
2013-08-21 |
先正达参股股份有限公司 |
杀虫化合物
|
|
EP2474624B1
(en)
|
2011-01-05 |
2016-08-17 |
Daniela Kandioler |
Response prediction in cancer treatment (p53 adapted cancer therapy)
|
|
EP2474625B1
(en)
|
2011-01-05 |
2016-11-02 |
Daniela Kandioler |
Method for determining the p53 status of a tumour
|
|
WO2012094755A1
(en)
|
2011-01-14 |
2012-07-19 |
Theratechnologies Inc. |
Assessment of igf-1 levels in hiv-infected subjects and uses thereof
|
|
JP5950587B2
(ja)
|
2011-02-28 |
2016-07-13 |
キヤノン株式会社 |
多孔質ガラスの製造方法および光学部材の製造方法
|
|
WO2012122059A1
(en)
|
2011-03-04 |
2012-09-13 |
New York University |
Hydrogen bond surrogate macrocycles as modulators of ras
|
|
US9376467B2
(en)
|
2011-03-09 |
2016-06-28 |
Jitsubo Co., Ltd. |
Cross-linked peptides containing non-peptide cross-linked structure, method for synthesizing cross-linked peptides, and novel organic compound used in method
|
|
TWI494312B
(zh)
|
2011-03-10 |
2015-08-01 |
Daiichi Sankyo Co Ltd |
二螺吡咯啶衍生物
|
|
US20140213502A1
(en)
|
2011-04-29 |
2014-07-31 |
United States Department of Health and Human Services |
Chemical modification of apolipoprotein mimetic peptides for the production of therapeutic agents
|
|
WO2012173846A2
(en)
|
2011-06-06 |
2012-12-20 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
WO2012174423A1
(en)
|
2011-06-17 |
2012-12-20 |
President And Fellows Of Harvard College |
Stabilized polypeptides as regulators of rab gtpase function
|
|
US20140256912A1
(en)
|
2011-06-17 |
2014-09-11 |
President And Fellows Of Harvard College |
Stabilized Variant MAML Peptides and Uses Thereof
|
|
GB201110390D0
(en)
|
2011-06-20 |
2011-08-03 |
Medical Res Council |
Compounds for use in stabilising p53 mutants
|
|
US20120328692A1
(en)
|
2011-06-24 |
2012-12-27 |
University Of Maryland, Baltimore |
Potent d-peptide antagonists of mdm2 and mdmx for anticancer therapy
|
|
US20130123196A1
(en)
|
2011-08-31 |
2013-05-16 |
New York University |
Thioether-, ether-, and alkylamine-linked hydrogen bond surrogate peptidomimetics
|
|
EP3444262A3
(en)
|
2011-09-09 |
2019-04-10 |
Agency For Science, Technology And Research |
P53 activating peptides
|
|
JP6093770B2
(ja)
|
2011-09-27 |
2017-03-08 |
アムジエン・インコーポレーテツド |
癌の治療のためのｍｄｍ２阻害剤としての複素環化合物
|
|
WO2013059530A2
(en)
|
2011-10-18 |
2013-04-25 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
EP2768518A4
(en)
|
2011-10-18 |
2015-05-27 |
Aileron Therapeutics Inc |
PEPTIDOMIMETIC MACROCYCLES
|
|
US8987274B2
(en)
|
2011-10-28 |
2015-03-24 |
Merck Sharp & Dohme Corp |
Macrocycles that increase p53 activity and the uses thereof
|
|
US9408885B2
(en)
|
2011-12-01 |
2016-08-09 |
Vib Vzw |
Combinations of therapeutic agents for treating melanoma
|
|
US8796257B2
(en)
|
2011-12-02 |
2014-08-05 |
Naeja Pharmaceutical Inc. |
Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors
|
|
CA2761253A1
(en)
|
2011-12-07 |
2013-06-07 |
Vib Vzw |
Combinations of therapeutic agents for treating melanoma
|
|
WO2013116829A1
(en)
|
2012-02-03 |
2013-08-08 |
The Trustees Of Princeton University |
Novel engineered potent cytotoxic stapled bh3 peptides
|
|
WO2013123267A1
(en)
|
2012-02-15 |
2013-08-22 |
Aileron Therapeutics, Inc. |
Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
|
|
US8927500B2
(en)
|
2012-02-15 |
2015-01-06 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
US9890429B2
(en)
|
2012-02-29 |
2018-02-13 |
Dana-Farber Cancer Institute, Inc. |
Compositions, kits, and methods for the identification, assessment, prevention, and therapy of cancer
|
|
EP2820041B1
(en)
|
2012-03-02 |
2017-06-14 |
Ludwig Institute For Cancer Research Ltd. |
Iaspp phosphorylation and metastatic potential
|
|
US9216170B2
(en)
|
2012-03-19 |
2015-12-22 |
Hoffmann-La Roche Inc. |
Combination therapy for proliferative disorders
|
|
WO2013166319A1
(en)
|
2012-05-02 |
2013-11-07 |
Kansas State University Research Foundation |
Macrocyclic and peptidomimetic compounds as broad-spectrum antivirals against 3c or 3c-like proteases of picornaviruses, caliciviruses and coronaviruses
|
|
US20150159222A1
(en)
|
2012-07-31 |
2015-06-11 |
Novartis Ag |
Markers associated with human double minute 2 inhibitors
|
|
AU2013325099B2
(en)
|
2012-09-25 |
2018-11-15 |
The Walter And Eliza Hall Institute Of Medical Research |
Structure of insulin in complex with n- and c-terminal regions of the insulin receptor alpha-chain
|
|
ES2874525T3
(es)
|
2012-09-26 |
2021-11-05 |
Harvard College |
Péptidos grapados bloqueados con prolina y usos de los mismos
|
|
US20150225471A1
(en)
|
2012-10-01 |
2015-08-13 |
President And Fellows Of Harvard College |
Stabilized polypeptide insulin receptor modulators
|
|
AU2013337388B2
(en)
|
2012-11-01 |
2018-08-02 |
Aileron Therapeutics, Inc. |
Disubstituted amino acids and methods of preparation and use thereof
|
|
WO2014115080A1
(en)
|
2013-01-22 |
2014-07-31 |
Novartis Ag |
Pyrazolo[3,4-d]pyrimidinone compounds as inhibitors of the p53/mdm2 interaction
|
|
WO2014134201A1
(en)
|
2013-02-28 |
2014-09-04 |
Amgen Inc. |
A benzoic acid derivative mdm2 inhibitor for the treatment of cancer
|
|
WO2014138429A2
(en)
|
2013-03-06 |
2014-09-12 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and use thereof in regulating hif1alpha
|
|
CN105307667B
(zh)
|
2013-03-13 |
2019-04-19 |
哈佛大学的校长及成员们 |
钉合且缝合的多肽及其用途
|
|
JP2016515380A
(ja)
|
2013-03-15 |
2016-05-30 |
ライフ テクノロジーズ コーポレーション |
肺癌の分類及び実施可能性インデックス
|
|
US9198910B2
(en)
|
2013-04-04 |
2015-12-01 |
The Translational Genomics Research Institute |
Methods for the treatment of cancer
|
|
CA2909683A1
(en)
|
2013-04-16 |
2014-10-23 |
Memorial Sloan-Kettering Cancer Center |
Companion diagnostic for cdk4 inhibitors
|
|
WO2014197821A1
(en)
|
2013-06-06 |
2014-12-11 |
President And Fellows Of Harvard College |
Homeodomain fusion proteins and uses thereof
|
|
KR20160019547A
(ko)
|
2013-06-14 |
2016-02-19 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
안정화된 폴리펩티드 인슐린 수용체 조절제
|
|
AU2014286237B2
(en)
|
2013-07-03 |
2020-08-20 |
F. Hoffmann-La Roche Ag |
mRNA-based gene expression for personalizing patient cancer therapy with an MDM2 antagonist
|
|
US9268662B2
(en)
|
2013-08-01 |
2016-02-23 |
Oracle International Corporation |
Method and system for a high availability framework
|
|
CA2919837A1
(en)
|
2013-08-02 |
2015-02-05 |
Children's Hospital Medical Center |
Compositions and methods for treating disease states associated with activated t cells and/or b cells
|
|
JP2017503749A
(ja)
|
2013-10-01 |
2017-02-02 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
安定化されたポリペプチドおよびその使用
|
|
US20160115556A1
(en)
|
2013-10-19 |
2016-04-28 |
Trovagene, Inc. |
Detecting mutations in disease over time
|
|
NZ758548A
(en)
|
2013-11-11 |
2022-02-25 |
Amgen Inc |
Combination therapy including an mdm2 inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers
|
|
ES2785203T3
(es)
|
2013-12-05 |
2020-10-06 |
Hoffmann La Roche |
Tratamiento de combinación novedoso para leucemia mielógena aguda (LMA)
|
|
EP3086787B1
(en)
|
2013-12-23 |
2021-01-20 |
Novartis AG |
Pharmaceutical combinations
|
|
BR112016012506A8
(pt)
|
2013-12-23 |
2018-01-30 |
Novartis Ag |
combinações farmacêuticas, seus usos, e uso de um portador de dados
|
|
WO2015108175A1
(en)
|
2014-01-14 |
2015-07-23 |
Daiichi Sankyo Company, Limited |
Gene signatures associated with sensitivity to mdm2 inhibitors
|
|
US20170037086A1
(en)
|
2014-04-09 |
2017-02-09 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles with pth activity
|
|
US20170184604A1
(en)
|
2014-05-22 |
2017-06-29 |
The General Hospital Corporation |
Dd1alpha receptor and uses thereof in immune disorders
|
|
TW201613576A
(en)
|
2014-06-26 |
2016-04-16 |
Novartis Ag |
Intermittent dosing of MDM2 inhibitor
|
|
KR20170060042A
(ko)
|
2014-09-13 |
2017-05-31 |
노파르티스 아게 |
Alk 억제제의 조합 요법
|
|
MX2017003797A
(es)
|
2014-09-24 |
2017-06-15 |
Aileron Therapeutics Inc |
Macrociclos peptidomimeticos y usos de los mismos.
|
|
BR112017005736A2
(pt)
|
2014-09-24 |
2017-12-12 |
Aileron Therapeutics Inc |
macrociclos peptidomiméticos e formulações dos mesmos
|
|
EP3204514A1
(en)
|
2014-10-09 |
2017-08-16 |
Daiichi Sankyo Co., Ltd. |
Algorithms for gene signature-based predictor of sensitivity to mdm2 inhibitors
|
|
US20170227544A1
(en)
|
2014-10-10 |
2017-08-10 |
Hoffmann-La Roche Inc. |
Methods for personalizing patient cancer therapy with an mdm2 antagonist
|
|
US10302644B2
(en)
|
2014-11-04 |
2019-05-28 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for treating multiple myeloma
|
|
CA2969830A1
(en)
|
2014-12-24 |
2016-06-30 |
Genentech, Inc. |
Therapeutic, diagnostic and prognostic methods for cancer of the bladder
|
|
CN107614003A
(zh)
|
2015-03-20 |
2018-01-19 |
艾瑞朗医疗公司 |
拟肽大环化合物及其用途
|
|
WO2017004548A1
(en)
|
2015-07-01 |
2017-01-05 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
CN108026146A
(zh)
|
2015-07-02 |
2018-05-11 |
达纳-法伯癌症研究所股份有限公司 |
稳定的抗微生物肽
|
|
WO2017023933A2
(en)
|
2015-08-03 |
2017-02-09 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
US20170114098A1
(en)
|
2015-09-03 |
2017-04-27 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|
|
CN108368161A
(zh)
|
2015-09-10 |
2018-08-03 |
艾瑞朗医疗公司 |
作为mcl-1调节剂的拟肽大环化合物
|
|
US20170349638A1
(en)
|
2016-03-21 |
2017-12-07 |
Aileron Therapeutics, Inc. |
Companion diagnostic tool for peptidomimetic macrocycles
|
|
WO2017205786A1
(en)
|
2016-05-27 |
2017-11-30 |
Aileron Therapeutics, Inc. |
Cell permeable peptidomimetic macrocycles
|
|
US20170360881A1
(en)
|
2016-06-17 |
2017-12-21 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|
|
US20190185518A9
(en)
|
2017-03-09 |
2019-06-20 |
Aileron Therapeutics, Inc. |
Warhead-containing peptidomimetic macrocycles as modulators of bfl-1
|